SAG
IMGN

Sterne Agee Group’s Immunogen Inc IMGN Stock Holding History

Sterne Agee Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$244K Buy
+28,686
New +$208K 0.04% 316

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sterne Agee Group's IMGN Position: Q1 2015 in Review

Sterne Agee Group opened a new position in Immunogen Inc (IMGN) in Q1 2015: 28,686 shares worth $244K. The stake represents 0.04% of the portfolio and ranks #316 among its holdings.

141 funds tracked by Wall St. Rank hold IMGN as of Q1 2015.

  • Sterne Agee Group held 28,686 shares of Immunogen Inc worth $244K as of Q1 2015.
  • Immunogen Inc was a new Sterne Agee Group position in Q1 2015.
  • Immunogen Inc made up 0.04% of Sterne Agee Group's portfolio in Q1 2015, its #316 holding.
  • 141 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.